- Home
- CNTX vs KOPN Comparison
CNTX vs KOPN Comparison
Compare CNTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- KOPN
- Stock Information
- Founded
- CNTX 2015
- KOPN 1984
- Country
- CNTX United States
- KOPN United States
- Employees
- CNTX N/A
- KOPN N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- KOPN Semiconductors
- Sector
- CNTX Health Care
- KOPN Technology
- Exchange
- CNTX Nasdaq
- KOPN Nasdaq
- Market Cap
- CNTX 77.2M
- KOPN 85.7M
- IPO Year
- CNTX 2021
- KOPN 1992
- Fundamental
- Price
- CNTX $0.96
- KOPN $1.26
- Analyst Decision
- CNTX Strong Buy
- KOPN Strong Buy
- Analyst Count
- CNTX 5
- KOPN 4
- Target Price
- CNTX $6.70
- KOPN $2.50
- AVG Volume (30 Days)
- CNTX 1.1M
- KOPN 2.4M
- Earning Date
- CNTX 11-06-2024
- KOPN 03-13-2025
- Dividend Yield
- CNTX N/A
- KOPN N/A
- EPS Growth
- CNTX N/A
- KOPN N/A
- EPS
- CNTX N/A
- KOPN N/A
- Revenue
- CNTX N/A
- KOPN $44,266,305.00
- Revenue This Year
- CNTX N/A
- KOPN $21.40
- Revenue Next Year
- CNTX N/A
- KOPN $14.05
- P/E Ratio
- CNTX N/A
- KOPN N/A
- Revenue Growth
- CNTX N/A
- KOPN 0.60
- 52 Week Low
- CNTX $0.89
- KOPN $0.56
- 52 Week High
- CNTX $2.75
- KOPN $2.82
- Technical
- Relative Strength Index (RSI)
- CNTX 38.22
- KOPN 48.64
- Support Level
- CNTX $0.92
- KOPN $1.13
- Resistance Level
- CNTX $1.05
- KOPN $1.27
- Average True Range (ATR)
- CNTX 0.13
- KOPN 0.12
- MACD
- CNTX 0.01
- KOPN -0.03
- Stochastic Oscillator
- CNTX 17.78
- KOPN 28.85
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.